3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Esophageal Neoplasms
2
Craniopharyngioma
2
Wilms Tumor
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Solid Tumor
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Recurrent Head and Neck Carcinoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Meningioma
1
Malignant Brain Glioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Interventions
Bevacizumab
37
atezolizumab
25
durvalumab
24
Nivolumab
21
lenvatinib
20
tremelimumab
16
Specimen Handling
16
Magnetic Resonance Spectroscopy
13
sintilimab
12
pembrolizumab
11
Ipilimumab
10
tislelizumab
7
X-Rays
7
Immunoglobulin G
7
regorafenib
6
Sorafenib
6
Disulfides
6
Cyclophosphamide
6
cabozantinib
5
Radiotherapy
5
Radiosurgery
5
Blood Specimen Collection
5
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Fluorouracil
4
Ethiodized Oil
4
Biopsy
4
fludarabine
3
donafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Proton Therapy
×
90 days
×
Clear all
No trials found.